CBIZ, Inc. 10-Q Summary: Quarter Ended June 30, 2025
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2025, for CBIZ, Inc., a diversified professional services company operating through three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. The reporting period reflects the full impact of the Marcum LLP acquisition completed on November 1, 2024, which significantly expanded the company's revenue base and debt obligations.
Key Financial Metrics
| Metric | Q2 2025 | Q2 2024 | YTD 2025 | YTD 2024 |
|---|---|---|---|---|
| Revenue | $683.5 million | $420.0 million | $1,521.5 million | $914.3 million |
| Net Income | $41.9 million | $19.8 million | $164.7 million | $96.7 million |
| Diluted EPS | $0.66 | $0.39 | $2.58 | $1.92 |
| Operating Income | $60.3 million | $31.6 million | $260.3 million | $130.7 million |
| Operating Margin | 8.8% | 7.5% | 17.1% | 14.3% |
| Interest Expense | $27.9 million | $5.9 million | $53.0 million | $10.4 million |
| Cash from Operations (YTD) | $24.9 million | $24.4 million | N/A | N/A |
| Total Debt Outstanding | $1,573.7 million (as of June 30, 2025) | |||
| Available Liquidity | ~$370 million under Credit Facilities |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 62.7% in Q2 and 66.4% YTD compared to 2024. Approximately 60-64% of this growth is attributed to the Marcum acquisition.
- Profitability: Net income more than doubled in Q2 (112% increase) and grew 70% YTD. Operating margins improved due to scale, though interest expense rose significantly ($22.0 million increase in Q2) due to higher debt levels from the acquisition financing.
- Segment Performance:
- Financial Services: Revenue surged 84.3% in Q2, driven by traditional accounting and tax services from the acquisition.
- Benefits and Insurance Services: Revenue grew 4.6% in Q2, with improved margins (17.6% vs 14.6% prior year).
- National Practices: Revenue declined 12.1% in Q2 due to a reduction in a cost-plus contract with a single client.
- Debt Structure: The company operates under a $2.0 billion credit facility (Term Loan + Revolver). Outstanding debt increased to $1.57 billion, with a weighted average interest rate of 6.67% for the six months ended June 30, 2025.
Guidance, Outlook, and Risks
- Management Commentary: Management notes softness in demand for non-recurring project-based services due to the current economic and geopolitical environment, which may limit forecasting ability for the remainder of 2025. The primary capital priority is maximizing cash flow to pay down debt to preserve liquidity for future strategic acquisitions.
- Share Repurchases: The company repurchased 1.0 million shares for $71.3 million under the Right of First Refusal (ROFR) agreement related to the Marcum transaction. A separate $5.0 million share repurchase program is authorized through March 31, 2026.
- Unusual Items:
- Legal Settlement: A $12.5 million pre-tax gain was recorded in Q2 from a settlement with former employees.
- Deferred Compensation: Gains/losses on the non-qualified deferred compensation plan (rabbi trust) offset operating expenses but had no impact on pre-tax income or EPS.
- Risks and Contingencies:
- Cybersecurity Litigation: The company is a defendant in multidistrict litigation (MDL) regarding the May 2023 MOVEit Transfer cyberattack. The outcome is currently indeterminable.
- Acquisition Integration: Risks related to the integration of Marcum LLP, including potential goodwill impairment or failure to realize anticipated synergies.
- Debt Covenants: The company is currently compliant with leverage and interest coverage covenants, but increased leverage limits financial flexibility.
Investor Verification Checklist
- Debt Servicing Capacity: Verify the sustainability of the $1.57 billion debt load given the 6.67% interest rate and potential revenue softness in project-based services.
- Acquisition Synergies: Monitor the integration progress of Marcum LLP and the realization of projected cost savings and revenue cross-selling opportunities.
- Legal Exposure: Track developments in the MOVEit cyberattack MDL, as potential liabilities could be material.
- Working Capital Trends: Review Days Sales Outstanding (DSO), which stood at 87 days (TTM) as of June 30, 2025, to ensure collection efficiency remains stable post-acquisition.
- Shareholder Dilution: Assess the impact of the remaining 8.7 million shares to be issued to Marcum selling shareholders over the next 29 months.